Clinical Trial Update: Phase II Study of EMB-01 in Recurrent/Metastatic Colorectal Cancer Patients [Phase 2]

View source ↗

Summary

Phase II trial update for EMB-01 in recurrent/metastatic colorectal cancer; the study is currently recruiting. No results are reported yet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• EMB-01

Snippet

Sponsor: Shanghai EpimAb Biotherapeutics Co., Ltd. | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: RECRUITING